デフォルト表紙
市場調査レポート
商品コード
1140348

塩化コリン市場:形態別(粉末、液体)、用途別(動物飼料、石油・ガス、人間栄養、パーソナルケア、製薬、その他)- 世界の機会分析および産業予測、2021-2031年

Choline Chloride Market By Form (Powder, Liquid), By Application (Animal Feed, Oil and Gas, Human Nutrition, Personal Care, Pharmaceuticals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: | 発行: Allied Market Research | ページ情報: 英文 318 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
塩化コリン市場:形態別(粉末、液体)、用途別(動物飼料、石油・ガス、人間栄養、パーソナルケア、製薬、その他)- 世界の機会分析および産業予測、2021-2031年
出版日: 2022年08月01日
発行: Allied Market Research
ページ情報: 英文 318 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

塩化コリンの世界市場は、2021年に4億9440万米ドルとなり、2022年から2031年にかけてCAGR6.4%で成長し、2031年には9億1690万米ドルに達すると予測されます。

塩化コリンは、コリンのカチオンと塩化物のアニオンを持つ第4級アンモニウム塩です。

塩化コリンの世界市場の成長は、パーソナルケアおよび医薬品の最終用途産業における塩化コリンの使用量の増加によってもたらされています。塩化コリンは、リポタンパク質の合成を含む脂質の輸送および代謝を増加させるとともに、向精神薬としても作用するため、医薬品の製剤化に広く使用されています。医薬品の製剤には、製剤の効果を判定するための分析物が必要です。分析物の効率を測定するために、いくつかの医薬品標準物質が使用されており、これらは二次標準物質または認証標準物質として知られています。塩化コリンは主に認証標準物質として使用されており、これが主要な市場動向となっています。また、医薬品グレードの塩化コリンは、医薬品やバイオ医薬品の細胞培養液製品の生産用原料として広く使用されており、世界市場の需要を牽引しています。溶剤は、医薬品の賦形剤および製品の精製時に不可欠な重要な中間体化合物です。さらに、グリーンケミストリーへの関心の高まりは、製薬業界におけるバイオベース溶媒の成長にとって計り知れない機会を生み出しています。いくつかの研究は、医薬品の精製に使用される塩化コリンの効率性と持続可能性を示唆しています。これらのすべての要因は、総称して、世界市場の需要を急増しています。

しかし、塩化コリンを含む人間用栄養製品の過剰使用には、いくつかの副作用があります。塩化コリンを含む栄養補助食品は、1日3.5gを摂取することが規定されています。規定値を超えて過剰に使用すると、下痢や嘔吐感を引き起こします。また、妊娠中や授乳期には副作用が出ることがあります。また、塩化コリンを含む栄養剤を大量に摂取した場合、うっ血性心不全、脱水、多量の発汗、呼吸性アシドーシスなどの副作用が確認されています。

塩化コリンは、石油・ガス産業における探査、生産、精製工程で使用されています。塩化コリンは、探査中の機械シャフトを安定させ、効率的にビットを切断し、地下の安全性を高め、機械の回転速度を向上させる能力があるため、補助化学物質として使用されています。また、掘削泥水中の頁岩抑制剤としても使用されます。石油・ガスの生産・精製工程では、主に塩化カリウム(KCL)が粘土安定剤として使用されてきました。しかし、塩化コリンの構造的特性、有効性、環境に優しい特性により、他の粘土安定剤よりも実行可能な安定剤となり、世界市場の需要を牽引しています。また、塩化コリンは塩化物の放出を70%~75%抑えることができるため、KCLを超える粘土安定剤として広く採用される傾向にあります。粘土安定剤は、石油の掘削や精製において重要な役割を担っています。しかし、KCLはその抑制効果を増大させ、石油の純度を阻害する傾向があります。塩化コリンの質量分率が1~2%で、無機塩が3%以上含まれているため、抑制効果の抑制に適していることも、世界市場の需要を後押しする大きな要因となっています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析
  • 価格設定分析
  • 規制ガイドライン
  • バリューチェーン分析
  • 特許情勢
  • 主要規制の分析

第4章 塩化コリンの市場:形態別

  • 概要
    • 市場規模および予測
  • 粉体
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 液体
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第5章 塩化コリン市場:用途別

  • 概要
    • 市場規模および予測
  • 動物飼料
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 石油・ガス
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • ヒューマンニュートリション
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • パーソナルケア
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 医薬品
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第6章 塩化コリン市場:地域別

  • 概要
    • 市場規模および予測
  • 北米
    • 主要動向と機会
    • 北米市場規模・予測:形態別
    • 北米市場規模・予測:用途別
    • 北米市場規模・予測:国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州の市場規模・予測:形態別
    • 欧州市場規模・予測:アプリケーション別
    • 欧州市場規模・予測:国別
      • ドイツ
      • 英国
      • フランス
      • スペイン
      • イタリア
      • その他の欧州
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測:形態別
    • アジア太平洋地域の市場規模・予測:用途別
    • アジア太平洋地域の市場規模・予測:国別
      • 中国
      • インド
      • 日本
      • 韓国
      • オーストラリア
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測:形態別
    • LAMEAの市場規模・予測:アプリケーション別
    • LAMEAの市場規模・予測:国別
      • ブラジル
      • サウジアラビア
      • 南アフリカ共和国
      • LAMEAの残りの地域

第7章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主な発展

第8章 企業プロファイル

  • ALGRY Quimica S.L
  • Balaji Amines Ltd.
  • Balchem Inc.
  • BASF SE
  • Eastman Chemical Company
  • Imperial Group Limited
  • Jubilant Ingrevia Limited
  • Kemin Industries Inc.
  • Liaoning Biochem Co. Ltd.
  • Merck KGaA
  • Nuproxa Switzerland Ltd.
  • Pestell Nutrition Inc.
  • SDA Product
  • Spectrum Chemical
  • TOKYO CHEMICAL INDUSTRY CO., LTD.
図表

LIST OF TABLES

  • TABLE 1. GLOBAL CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 2. GLOBAL CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 3. CHOLINE CHLORIDE MARKET, FOR POWDER, BY REGION, 2021-2031 ($MILLION)
  • TABLE 4. CHOLINE CHLORIDE MARKET, FOR POWDER, BY REGION, 2021-2031 (KILOTON)
  • TABLE 5. CHOLINE CHLORIDE MARKET FOR POWDER, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. CHOLINE CHLORIDE MARKET FOR POWDER, BY COUNTRY, 2021-2031 (KILOTON)
  • TABLE 7. CHOLINE CHLORIDE MARKET, FOR LIQUID, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. CHOLINE CHLORIDE MARKET, FOR LIQUID, BY REGION, 2021-2031 (KILOTON)
  • TABLE 9. CHOLINE CHLORIDE MARKET FOR LIQUID, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. CHOLINE CHLORIDE MARKET FOR LIQUID, BY COUNTRY, 2021-2031 (KILOTON)
  • TABLE 11. GLOBAL CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 12. GLOBAL CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 13. CHOLINE CHLORIDE MARKET, FOR ANIMAL FEED, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. CHOLINE CHLORIDE MARKET, FOR ANIMAL FEED, BY REGION, 2021-2031 (KILOTON)
  • TABLE 15. CHOLINE CHLORIDE MARKET FOR ANIMAL FEED, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 16. CHOLINE CHLORIDE MARKET FOR ANIMAL FEED, BY COUNTRY, 2021-2031 (KILOTON)
  • TABLE 17. CHOLINE CHLORIDE MARKET, FOR OIL AND GAS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. CHOLINE CHLORIDE MARKET, FOR OIL AND GAS, BY REGION, 2021-2031 (KILOTON)
  • TABLE 19. CHOLINE CHLORIDE MARKET FOR OIL AND GAS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 20. CHOLINE CHLORIDE MARKET FOR OIL AND GAS, BY COUNTRY, 2021-2031 (KILOTON)
  • TABLE 21. CHOLINE CHLORIDE MARKET, FOR HUMAN NUTRITION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. CHOLINE CHLORIDE MARKET, FOR HUMAN NUTRITION, BY REGION, 2021-2031 (KILOTON)
  • TABLE 23. CHOLINE CHLORIDE MARKET FOR HUMAN NUTRITION, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 24. CHOLINE CHLORIDE MARKET FOR HUMAN NUTRITION, BY COUNTRY, 2021-2031 (KILOTON)
  • TABLE 25. CHOLINE CHLORIDE MARKET, FOR PERSONAL CARE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. CHOLINE CHLORIDE MARKET, FOR PERSONAL CARE, BY REGION, 2021-2031 (KILOTON)
  • TABLE 27. CHOLINE CHLORIDE MARKET FOR PERSONAL CARE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 28. CHOLINE CHLORIDE MARKET FOR PERSONAL CARE, BY COUNTRY, 2021-2031 (KILOTON)
  • TABLE 29. CHOLINE CHLORIDE MARKET, FOR PHARMACEUTICALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 30. CHOLINE CHLORIDE MARKET, FOR PHARMACEUTICALS, BY REGION, 2021-2031 (KILOTON)
  • TABLE 31. CHOLINE CHLORIDE MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 32. CHOLINE CHLORIDE MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2021-2031 (KILOTON)
  • TABLE 33. CHOLINE CHLORIDE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 34. CHOLINE CHLORIDE MARKET, FOR OTHERS, BY REGION, 2021-2031 (KILOTON)
  • TABLE 35. CHOLINE CHLORIDE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 36. CHOLINE CHLORIDE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (KILOTON)
  • TABLE 37. CHOLINE CHLORIDE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 38. CHOLINE CHLORIDE MARKET, BY REGION, 2021-2031 (KILOTON)
  • TABLE 39. NORTH AMERICA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 40. NORTH AMERICA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 41. NORTH AMERICA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 42. NORTH AMERICA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 43. NORTH AMERICA CHOLINE CHLORIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 44. NORTH AMERICA CHOLINE CHLORIDE MARKET, BY COUNTRY, 2021-2031 (KILOTON)
  • TABLE 45. U.S. CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 46. U.S. CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 47. U.S. CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 48. U.S. CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 49. CANADA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 50. CANADA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 51. CANADA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 52. CANADA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 53. MEXICO CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 54. MEXICO CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 55. MEXICO CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 56. MEXICO CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 57. EUROPE CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 58. EUROPE CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 59. EUROPE CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 60. EUROPE CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 61. EUROPE CHOLINE CHLORIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 62. EUROPE CHOLINE CHLORIDE MARKET, BY COUNTRY, 2021-2031 (KILOTON)
  • TABLE 63. GERMANY CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 64. GERMANY CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 65. GERMANY CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 66. GERMANY CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 67. UK CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 68. UK CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 69. UK CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 70. UK CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 71. FRANCE CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 72. FRANCE CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 73. FRANCE CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 74. FRANCE CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 75. SPAIN CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 76. SPAIN CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 77. SPAIN CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 78. SPAIN CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 79. ITALY CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 80. ITALY CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 81. ITALY CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 82. ITALY CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 83. REST OF EUROPE CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 84. REST OF EUROPE CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 85. REST OF EUROPE CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 86. REST OF EUROPE CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 87. ASIA-PACIFIC CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 88. ASIA-PACIFIC CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 89. ASIA-PACIFIC CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 90. ASIA-PACIFIC CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 91. ASIA-PACIFIC CHOLINE CHLORIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 92. ASIA-PACIFIC CHOLINE CHLORIDE MARKET, BY COUNTRY, 2021-2031 (KILOTON)
  • TABLE 93. CHINA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 94. CHINA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 95. CHINA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 96. CHINA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 97. INDIA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 98. INDIA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 99. INDIA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 100. INDIA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 101. JAPAN CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 102. JAPAN CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 103. JAPAN CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 104. JAPAN CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 105. SOUTH KOREA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 106. SOUTH KOREA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 107. SOUTH KOREA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 108. SOUTH KOREA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 109. AUSTRALIA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 110. AUSTRALIA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 111. AUSTRALIA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 112. AUSTRALIA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 113. REST OF ASIA-PACIFIC CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 114. REST OF ASIA-PACIFIC CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 115. REST OF ASIA-PACIFIC CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 116. REST OF ASIA-PACIFIC CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 117. LAMEA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 118. LAMEA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 119. LAMEA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 120. LAMEA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 121. LAMEA CHOLINE CHLORIDE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 122. LAMEA CHOLINE CHLORIDE MARKET, BY COUNTRY, 2021-2031 (KILOTON)
  • TABLE 123. BRAZIL CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 124. BRAZIL CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 125. BRAZIL CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 126. BRAZIL CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 127. SAUDI ARABIA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 128. SAUDI ARABIA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 129. SAUDI ARABIA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 130. SAUDI ARABIA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 131. SOUTH AFRICA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 132. SOUTH AFRICA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 133. SOUTH AFRICA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 134. SOUTH AFRICA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 135. REST OF LAMEA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 136. REST OF LAMEA CHOLINE CHLORIDE MARKET, BY FORM, 2021-2031 (KILOTON)
  • TABLE 137. REST OF LAMEA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 138. REST OF LAMEA CHOLINE CHLORIDE MARKET, BY APPLICATION, 2021-2031 (KILOTON)
  • TABLE 139.ALGRY QUIMICA S.L: COMPANY SNAPSHOT
  • TABLE 140.ALGRY QUIMICA S.L: OPERATING SEGMENTS
  • TABLE 141.ALGRY QUIMICA S.L: PRODUCT PORTFOLIO
  • TABLE 142.ALGRY QUIMICA S.L: NET SALES,
  • TABLE 143.ALGRY QUIMICA S.L: KEY STRATERGIES
  • TABLE 144.BALAJI AMINES LTD.: COMPANY SNAPSHOT
  • TABLE 145.BALAJI AMINES LTD.: OPERATING SEGMENTS
  • TABLE 146.BALAJI AMINES LTD.: PRODUCT PORTFOLIO
  • TABLE 147.BALAJI AMINES LTD.: NET SALES,
  • TABLE 148.BALAJI AMINES LTD.: KEY STRATERGIES
  • TABLE 149.BALCHEM INC.: COMPANY SNAPSHOT
  • TABLE 150.BALCHEM INC.: OPERATING SEGMENTS
  • TABLE 151.BALCHEM INC.: PRODUCT PORTFOLIO
  • TABLE 152.BALCHEM INC.: NET SALES,
  • TABLE 153.BALCHEM INC.: KEY STRATERGIES
  • TABLE 154.BASF SE: COMPANY SNAPSHOT
  • TABLE 155.BASF SE: OPERATING SEGMENTS
  • TABLE 156.BASF SE: PRODUCT PORTFOLIO
  • TABLE 157.BASF SE: NET SALES,
  • TABLE 158.BASF SE: KEY STRATERGIES
  • TABLE 159.EASTMAN CHEMICAL COMPANY: COMPANY SNAPSHOT
  • TABLE 160.EASTMAN CHEMICAL COMPANY: OPERATING SEGMENTS
  • TABLE 161.EASTMAN CHEMICAL COMPANY: PRODUCT PORTFOLIO
  • TABLE 162.EASTMAN CHEMICAL COMPANY: NET SALES,
  • TABLE 163.EASTMAN CHEMICAL COMPANY: KEY STRATERGIES
  • TABLE 164.IMPERIAL GROUP LIMITED: COMPANY SNAPSHOT
  • TABLE 165.IMPERIAL GROUP LIMITED: OPERATING SEGMENTS
  • TABLE 166.IMPERIAL GROUP LIMITED: PRODUCT PORTFOLIO
  • TABLE 167.IMPERIAL GROUP LIMITED: NET SALES,
  • TABLE 168.IMPERIAL GROUP LIMITED: KEY STRATERGIES
  • TABLE 169.JUBILANT INGREVIA LIMITED: COMPANY SNAPSHOT
  • TABLE 170.JUBILANT INGREVIA LIMITED: OPERATING SEGMENTS
  • TABLE 171.JUBILANT INGREVIA LIMITED: PRODUCT PORTFOLIO
  • TABLE 172.JUBILANT INGREVIA LIMITED: NET SALES,
  • TABLE 173.JUBILANT INGREVIA LIMITED: KEY STRATERGIES
  • TABLE 174.KEMIN INDUSTRIES INC.: COMPANY SNAPSHOT
  • TABLE 175.KEMIN INDUSTRIES INC.: OPERATING SEGMENTS
  • TABLE 176.KEMIN INDUSTRIES INC.: PRODUCT PORTFOLIO
  • TABLE 177.KEMIN INDUSTRIES INC.: NET SALES,
  • TABLE 178.KEMIN INDUSTRIES INC.: KEY STRATERGIES
  • TABLE 179.LIAONING BIOCHEM CO. LTD.: COMPANY SNAPSHOT
  • TABLE 180.LIAONING BIOCHEM CO. LTD.: OPERATING SEGMENTS
  • TABLE 181.LIAONING BIOCHEM CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 182.LIAONING BIOCHEM CO. LTD.: NET SALES,
  • TABLE 183.LIAONING BIOCHEM CO. LTD.: KEY STRATERGIES
  • TABLE 184.MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 185.MERCK KGAA: OPERATING SEGMENTS
  • TABLE 186.MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 187.MERCK KGAA: NET SALES,
  • TABLE 188.MERCK KGAA: KEY STRATERGIES
  • TABLE 189.NUPROXA SWITZERLAND LTD.: COMPANY SNAPSHOT
  • TABLE 190.NUPROXA SWITZERLAND LTD.: OPERATING SEGMENTS
  • TABLE 191.NUPROXA SWITZERLAND LTD.: PRODUCT PORTFOLIO
  • TABLE 192.NUPROXA SWITZERLAND LTD.: NET SALES,
  • TABLE 193.NUPROXA SWITZERLAND LTD.: KEY STRATERGIES
  • TABLE 194.PESTELL NUTRITION INC.: COMPANY SNAPSHOT
  • TABLE 195.PESTELL NUTRITION INC.: OPERATING SEGMENTS
  • TABLE 196.PESTELL NUTRITION INC.: PRODUCT PORTFOLIO
  • TABLE 197.PESTELL NUTRITION INC.: NET SALES,
  • TABLE 198.PESTELL NUTRITION INC.: KEY STRATERGIES
  • TABLE 199.SDA PRODUCT: COMPANY SNAPSHOT
  • TABLE 200.SDA PRODUCT: OPERATING SEGMENTS
  • TABLE 201.SDA PRODUCT: PRODUCT PORTFOLIO
  • TABLE 202.SDA PRODUCT: NET SALES,
  • TABLE 203.SDA PRODUCT: KEY STRATERGIES
  • TABLE 204.SPECTRUM CHEMICAL: COMPANY SNAPSHOT
  • TABLE 205.SPECTRUM CHEMICAL: OPERATING SEGMENTS
  • TABLE 206.SPECTRUM CHEMICAL: PRODUCT PORTFOLIO
  • TABLE 207.SPECTRUM CHEMICAL: NET SALES,
  • TABLE 208.SPECTRUM CHEMICAL: KEY STRATERGIES
  • TABLE 209.TOKYO CHEMICAL INDUSTRY CO., LTD.: COMPANY SNAPSHOT
  • TABLE 210.TOKYO CHEMICAL INDUSTRY CO., LTD.: OPERATING SEGMENTS
  • TABLE 211.TOKYO CHEMICAL INDUSTRY CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 212.TOKYO CHEMICAL INDUSTRY CO., LTD.: NET SALES,
  • TABLE 213.TOKYO CHEMICAL INDUSTRY CO., LTD.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.CHOLINE CHLORIDE MARKET SEGMENTATION
  • FIGURE 2.CHOLINE CHLORIDE MARKET,2021-2031
  • FIGURE 3.CHOLINE CHLORIDE MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.CHOLINE CHLORIDE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PRICING ANALYSIS
  • FIGURE 13.REGULATORY GUIDELINES
  • FIGURE 14.VALUE CHAIN ANALYSIS
  • FIGURE 15.PATENT ANALYSIS BY COMPANY
  • FIGURE 16.PATENT ANALYSIS BY COUNTRY
  • FIGURE 17.KEY REGULATION ANALYSIS
  • FIGURE 18.CHOLINE CHLORIDE MARKET,BY FORM,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF POWDER CHOLINE CHLORIDE MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF LIQUID CHOLINE CHLORIDE MARKET,2021-2031(%)
  • FIGURE 21.CHOLINE CHLORIDE MARKET,BY APPLICATION,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF ANIMAL FEED CHOLINE CHLORIDE MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF OIL AND GAS CHOLINE CHLORIDE MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF HUMAN NUTRITION CHOLINE CHLORIDE MARKET,2021-2031(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF PERSONAL CARE CHOLINE CHLORIDE MARKET,2021-2031(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICALS CHOLINE CHLORIDE MARKET,2021-2031(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OTHERS CHOLINE CHLORIDE MARKET,2021-2031(%)
  • FIGURE 28.CHOLINE CHLORIDE MARKET BY REGION,2021
  • FIGURE 29.U.S. CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 30.CANADA CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 31.MEXICO CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 32.GERMANY CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 33.UK CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 34.FRANCE CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 35.SPAIN CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 36.ITALY CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 37.REST OF EUROPE CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 38.CHINA CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 39.INDIA CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 40.JAPAN CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 41.SOUTH KOREA CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 42.AUSTRALIA CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 43.REST OF ASIA-PACIFIC CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 44.BRAZIL CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 45.SAUDI ARABIA CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 46.SOUTH AFRICA CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 47.REST OF LAMEA CHOLINE CHLORIDE MARKET,2021-2031($MILLION)
  • FIGURE 48. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 51.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 52.COMPETITIVE DASHBOARD
  • FIGURE 53.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 54.ALGRY QUIMICA S.L.: NET SALES ,($MILLION)
  • FIGURE 55.BALAJI AMINES LTD..: NET SALES ,($MILLION)
  • FIGURE 56.BALCHEM INC..: NET SALES ,($MILLION)
  • FIGURE 57.BASF SE.: NET SALES ,($MILLION)
  • FIGURE 58.EASTMAN CHEMICAL COMPANY.: NET SALES ,($MILLION)
  • FIGURE 59.IMPERIAL GROUP LIMITED.: NET SALES ,($MILLION)
  • FIGURE 60.JUBILANT INGREVIA LIMITED.: NET SALES ,($MILLION)
  • FIGURE 61.KEMIN INDUSTRIES INC..: NET SALES ,($MILLION)
  • FIGURE 62.LIAONING BIOCHEM CO. LTD..: NET SALES ,($MILLION)
  • FIGURE 63.MERCK KGAA.: NET SALES ,($MILLION)
  • FIGURE 64.NUPROXA SWITZERLAND LTD..: NET SALES ,($MILLION)
  • FIGURE 65.PESTELL NUTRITION INC..: NET SALES ,($MILLION)
  • FIGURE 66.SDA PRODUCT.: NET SALES ,($MILLION)
  • FIGURE 67.SPECTRUM CHEMICAL.: NET SALES ,($MILLION)
  • FIGURE 68.TOKYO CHEMICAL INDUSTRY CO., LTD..: NET SALES ,($MILLION)
目次
Product Code: A17271

The global choline chloride market was valued at $494.4 million in 2021, and is projected to reach $916.9 million by 2031, growing at a CAGR of 6.4% from 2022 to 2031.

Choline chloride is a quaternary ammonium salt with choline cation and chloride anion.

The growth of the global choline chloride market is driven by increase in use of choline chloride in personal care and pharmaceutical end-use industries. Choline chloride acts as a lipotropic agent which increase the transport and metabolism of lipids including synthesis of lipoprotein and also act as a nootropic agent, thus making it widely used during formulation of pharmaceutical products. Pharmaceutical formulations require analyte for determination of the efficiency of the formulations. Several pharmaceutical reference standard are used for determination of analyte efficiency and these are known as secondary standards or certified reference materials. Choline chloride is mainly used as certified reference material is the key market trend. In addition, pharma grade choline chloride is used widely as a raw material for production of pharma or biopharmaceutical cell culture media products drives the demand for the global market. Solvents are important intermediate compounds that are vital during purification of pharmaceutical excipients and products. Moreover, growing concern over green chemistry has created immense opportunities for growth of bio-based solvents in pharmaceutical industry. Several studies suggest the efficiency and sustainability of choline chloride being used as solvent for pharmaceutical purification. All these factors have collectively surged the demand for global market. 

However, there are several side effects associated with excessive use of human nutritional products containing choline chloride. As per the prescribed value, consumption of choline chloride containing human nutritional products is 3.5 grams per day. Excessive use over prescribed value leads to diarrhea and vomiting sensation. In addition, over usage leads to side effects during pregnancy and lactation period. Other side effects such as Congestive heart failure, Dehydration, Excessive sweating, and Respiratory acidosis, have been observed with consumption of large amount of human nutritional products containing choline chloride. 

Choline chloride is used in oil and gas industry during exploration, production, and refining process. Choline chloride is used as an auxiliary chemical compound owing to its ability to stabilize machine shafts during exploration, deliver efficient bit cuttings, increase the underground safety and improves machine's rotational speed. Moreover, it can also be used as shale inhibitor in drilling fluids. Mainly potassium chloride (KCL) was used as clay stabilizer during oil and natural gas production and purification. However, owing to choline chloride structural characteristics, effectiveness and environment friendly characteristics makes it viable stabilizers over other clay stabilizers drives the demand of the global market. In addition, choline chloride tend to minimize the release of chloride content by 70%-75% making it widely adopted clay stabilizer over KCL. Clay stabilizers play important role during petroleum drilling and purification. However, KCL tend to escalate the inhibitory effect thereby hampering petroleum purity. The mass fraction of choline chloride is 1%-2% and contains inorganic salt is over 3% making it suitable to prohibit inhibitory effect is another considerable factor driving the demand of the global market.

The choline chloride market is segmented on the basis of form, application, and region. By form, the market is segregated into powder and liquid. By application, it is segregated into animal feed, oil and gas, human nutrition, personal care, pharmaceuticals, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The global chromatography resins market profiles leading players that include Cytiva Lifesciences, Bio-Rad Laboratories Inc., Sartorius AG, Generon, Tosoh Bioscience, Bio-Works, Repligen Corporation, LAF-Biotechnology, JNC Corporation, Anatrace Products LLC. The global chromatography resins market report provides in-depth competitive analysis as well as profiles of these major players 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the choline chloride market analysis from 2021 to 2031 to identify the prevailing choline chloride market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the choline chloride market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global choline chloride market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Form

  • Powder
  • Liquid

By Application

  • Animal Feed
  • Oil and Gas
  • Human Nutrition
  • Personal Care
  • Pharmaceuticals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest Of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • ALGRY Quimica S.L
    • Balaji Amines Ltd.
    • Balchem Inc.
    • BASF SE
    • Eastman Chemical Company
    • Imperial Group Limited
    • Jubilant Ingrevia Limited
    • Kemin Industries Inc.
    • Liaoning Biochem Co. Ltd.
    • Merck KGaA
    • Nuproxa Switzerland Ltd.
    • Pestell Nutrition Inc.
    • SDA Product
    • Spectrum Chemical
    • TOKYO CHEMICAL INDUSTRY CO., LTD.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Pricing Analysis
  • 3.8.Regulatory Guidelines
  • 3.9.Value Chain Analysis
  • 3.10.Patent Landscape
  • 3.11.Key Regulation Analysis

CHAPTER 4: CHOLINE CHLORIDE MARKET, BY FORM

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Powder
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Liquid
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: CHOLINE CHLORIDE MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Animal Feed
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Oil and Gas
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Human Nutrition
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Personal Care
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country
  • 5.6 Pharmaceuticals
    • 5.6.1 Key market trends, growth factors and opportunities
    • 5.6.2 Market size and forecast, by region
    • 5.6.3 Market analysis by country
  • 5.7 Others
    • 5.7.1 Key market trends, growth factors and opportunities
    • 5.7.2 Market size and forecast, by region
    • 5.7.3 Market analysis by country

CHAPTER 6: CHOLINE CHLORIDE MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Form
    • 6.2.3 North America Market size and forecast, by Application
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Market size and forecast, by Form
      • 6.2.4.1.2 Market size and forecast, by Application
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Market size and forecast, by Form
      • 6.2.4.2.2 Market size and forecast, by Application
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Market size and forecast, by Form
      • 6.2.4.3.2 Market size and forecast, by Application
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Form
    • 6.3.3 Europe Market size and forecast, by Application
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Market size and forecast, by Form
      • 6.3.4.1.2 Market size and forecast, by Application
      • 6.3.4.2 UK
      • 6.3.4.2.1 Market size and forecast, by Form
      • 6.3.4.2.2 Market size and forecast, by Application
      • 6.3.4.3 France
      • 6.3.4.3.1 Market size and forecast, by Form
      • 6.3.4.3.2 Market size and forecast, by Application
      • 6.3.4.4 Spain
      • 6.3.4.4.1 Market size and forecast, by Form
      • 6.3.4.4.2 Market size and forecast, by Application
      • 6.3.4.5 Italy
      • 6.3.4.5.1 Market size and forecast, by Form
      • 6.3.4.5.2 Market size and forecast, by Application
      • 6.3.4.6 Rest of Europe
      • 6.3.4.6.1 Market size and forecast, by Form
      • 6.3.4.6.2 Market size and forecast, by Application
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Form
    • 6.4.3 Asia-Pacific Market size and forecast, by Application
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 China
      • 6.4.4.1.1 Market size and forecast, by Form
      • 6.4.4.1.2 Market size and forecast, by Application
      • 6.4.4.2 India
      • 6.4.4.2.1 Market size and forecast, by Form
      • 6.4.4.2.2 Market size and forecast, by Application
      • 6.4.4.3 Japan
      • 6.4.4.3.1 Market size and forecast, by Form
      • 6.4.4.3.2 Market size and forecast, by Application
      • 6.4.4.4 South Korea
      • 6.4.4.4.1 Market size and forecast, by Form
      • 6.4.4.4.2 Market size and forecast, by Application
      • 6.4.4.5 Australia
      • 6.4.4.5.1 Market size and forecast, by Form
      • 6.4.4.5.2 Market size and forecast, by Application
      • 6.4.4.6 Rest of Asia-Pacific
      • 6.4.4.6.1 Market size and forecast, by Form
      • 6.4.4.6.2 Market size and forecast, by Application
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Form
    • 6.5.3 LAMEA Market size and forecast, by Application
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Brazil
      • 6.5.4.1.1 Market size and forecast, by Form
      • 6.5.4.1.2 Market size and forecast, by Application
      • 6.5.4.2 Saudi Arabia
      • 6.5.4.2.1 Market size and forecast, by Form
      • 6.5.4.2.2 Market size and forecast, by Application
      • 6.5.4.3 South Africa
      • 6.5.4.3.1 Market size and forecast, by Form
      • 6.5.4.3.2 Market size and forecast, by Application
      • 6.5.4.4 Rest of LAMEA
      • 6.5.4.4.1 Market size and forecast, by Form
      • 6.5.4.4.2 Market size and forecast, by Application

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 ALGRY Quimica S.L
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 Balaji Amines Ltd.
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Balchem Inc.
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 BASF SE
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 Eastman Chemical Company
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 Imperial Group Limited
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 Jubilant Ingrevia Limited
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 Kemin Industries Inc.
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Liaoning Biochem Co. Ltd.
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Merck KGaA
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments
  • 8.11 Nuproxa Switzerland Ltd.
    • 8.11.1 Company overview
    • 8.11.2 Company snapshot
    • 8.11.3 Operating business segments
    • 8.11.4 Product portfolio
    • 8.11.5 Business performance
    • 8.11.6 Key strategic moves and developments
  • 8.12 Pestell Nutrition Inc.
    • 8.12.1 Company overview
    • 8.12.2 Company snapshot
    • 8.12.3 Operating business segments
    • 8.12.4 Product portfolio
    • 8.12.5 Business performance
    • 8.12.6 Key strategic moves and developments
  • 8.13 SDA Product
    • 8.13.1 Company overview
    • 8.13.2 Company snapshot
    • 8.13.3 Operating business segments
    • 8.13.4 Product portfolio
    • 8.13.5 Business performance
    • 8.13.6 Key strategic moves and developments
  • 8.14 Spectrum Chemical
    • 8.14.1 Company overview
    • 8.14.2 Company snapshot
    • 8.14.3 Operating business segments
    • 8.14.4 Product portfolio
    • 8.14.5 Business performance
    • 8.14.6 Key strategic moves and developments
  • 8.15 TOKYO CHEMICAL INDUSTRY CO., LTD.
    • 8.15.1 Company overview
    • 8.15.2 Company snapshot
    • 8.15.3 Operating business segments
    • 8.15.4 Product portfolio
    • 8.15.5 Business performance
    • 8.15.6 Key strategic moves and developments